These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 38694509)
1. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation. Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q Front Immunol; 2024; 15():1371584. PubMed ID: 38694509 [TBL] [Abstract][Full Text] [Related]
2. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms. Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936 [TBL] [Abstract][Full Text] [Related]
3. DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma. Zhu D; Feng H; Zhang Z; Li J; Li Y; Hou T Cancer Med; 2024 Aug; 13(15):e70043. PubMed ID: 39087856 [TBL] [Abstract][Full Text] [Related]
4. Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma. Zhou R; Sun Z; Zhou R; Wang M; Zhuo Q; Deng X; Wang Z; Xu Y Med Oncol; 2024 Oct; 41(11):285. PubMed ID: 39402288 [TBL] [Abstract][Full Text] [Related]
5. SMC4 serves as a potential marker for the diagnosis and prognosis of colon adenocarcinoma. Yang D; Cheng W; Liu Y; Ma L; Sun Y; Wang H; Liu H; Nan L; Yang Y; Wang X Int J Immunopathol Pharmacol; 2024; 38():3946320241286565. PubMed ID: 39423024 [TBL] [Abstract][Full Text] [Related]
6. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma. Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538 [TBL] [Abstract][Full Text] [Related]
7. AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma. Li D; Liu Z; Ding X; Qin Z Biomed Res Int; 2021; 2021():3108933. PubMed ID: 34938806 [TBL] [Abstract][Full Text] [Related]
8. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma. Yang M; He H; Peng T; Lu Y; Yu J Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038 [TBL] [Abstract][Full Text] [Related]
9. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA. Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999 [No Abstract] [Full Text] [Related]
10. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis. Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224 [TBL] [Abstract][Full Text] [Related]
11. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients. Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303 [TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma. Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of regulatory T cell-associated gene signatures to predict colon adenocarcinoma prognosis. Zhao X; Li X; Miao Z Int Immunopharmacol; 2024 May; 132():112034. PubMed ID: 38588631 [TBL] [Abstract][Full Text] [Related]
14. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study. Ding K; Zhou M; Wang H; Zhang S; Metaxas DN Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192 [TBL] [Abstract][Full Text] [Related]
15. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
16. Generation of novel lipid metabolism-based signatures to predict prognosis and immunotherapy response for colorectal adenocarcinoma. Wang Y; Yao J; Zhang Z; Wei L; Wang S Sci Rep; 2024 Jul; 14(1):17158. PubMed ID: 39060344 [TBL] [Abstract][Full Text] [Related]
17. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms. Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423 [TBL] [Abstract][Full Text] [Related]
18. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. Jiang C; Liu Y; Wen S; Xu C; Gu L Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186 [TBL] [Abstract][Full Text] [Related]
19. Identification of key lncRNAs in the carcinogenesis and progression of colon adenocarcinoma by co-expression network analysis. Jiang S; Tan B; Zhang X J Cell Biochem; 2019 Apr; 120(4):6490-6501. PubMed ID: 30430631 [TBL] [Abstract][Full Text] [Related]
20. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma. Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014 [No Abstract] [Full Text] [Related] [Next] [New Search]